No longer committed to science - Avis employé Senior Research Scientist Merck

2,0
2 avr. 2017
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Good benefits since it's a large company and pay is descent. That's about it.

Inconvénients

I worked here before I got my Ph.D. and really loved the company. They were dedicated to science and doing things right. Then I went to get my Ph.D. in chemistry and came back to work for them. It was all changed. Now it was all about outsourcing and bringing value to the stock holders and typical b.s. they feed you at big companies. Management was reorganizing every 6 months. It was a disaster and no one really cared about science anymore. It's sad cause Merck was a great company that really tried to solve health problems. No longer the case.

Découvrez plus d’avis sur Merck

5,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent company to work with.

Inconvénients

No cons encountered so far

4,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Inconvénients

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Voir les avis par: Utile|Évaluation|Date|Tout